• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对人源和鼠源胞质胸苷激酶C末端部分的肽抗体的特性分析,该激酶是细胞增殖的标志物。

Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation.

作者信息

He Q, Skog S, Wang N, Eriksson S, Tribukait B

机构信息

Department of Medical Radiobiology, Karolinska Institute, Stockholm/Sweden.

出版信息

Eur J Cell Biol. 1996 Jun;70(2):117-24.

PMID:8793383
Abstract

An affinity-purified anti-TK1 antibody (pAb1) raised against a synthetic peptide (amino acids K211PGEAVAARKLFAPQ225) corresponding to part of the C-terminus of human cytosolic thymidine kinase (TK1) was produced and characterized by enzyme-linked immunosorbent assay, Western immunoblotting and immunoprecipitation as well as by immunostaining of intact cells. pAb1 recognized a single 25 kDa TK1 polypeptide in extracts of human and rodent cells. The protein was localized to the cytoplasm, as studied by immunohistochemistry and there was no staining in G1/G0 cells or mutant cells lacking TK1 activity, while it was high in S-phase and G2 cells. When series of peptides were tested for antibody binding in which alanine was replacing each of the other amino acids one by one, lysines 211 and 220, proline 212 and glutamic acid 214 were found to be important for antibody reactivity. These results indicate that amino acids 211-214, which may form a turn region, constitute a major recognition site for pAb1, and this structure may also be involved in the cell cycle-dependent modification of TK1, pAb1 is a very useful tool for studies of the cell cycle regulation of TK1, and it may be used to identify and quantify rapidly proliferating cells such as tumor cells.

摘要

制备了一种针对与人胞质胸苷激酶(TK1)C端部分相对应的合成肽(氨基酸序列为K211PGEAVAARKLFAPQ225)的亲和纯化抗TK1抗体(pAb1),并通过酶联免疫吸附测定、蛋白质免疫印迹和免疫沉淀以及完整细胞免疫染色对其进行了表征。pAb1在人和啮齿动物细胞提取物中识别出一条单一的25 kDa TK1多肽。通过免疫组织化学研究发现该蛋白定位于细胞质中,在G1/G0期细胞或缺乏TK1活性的突变细胞中无染色,而在S期和G2期细胞中染色较强。当测试一系列其中丙氨酸逐个取代其他氨基酸的肽与抗体的结合时,发现赖氨酸211和220、脯氨酸212和谷氨酸214对抗体反应性很重要。这些结果表明,可能形成一个转角区域的氨基酸211 - 214构成了pAb1的主要识别位点,并且该结构可能也参与了TK1的细胞周期依赖性修饰。pAb1是研究TK1细胞周期调控的非常有用的工具,它可用于识别和定量快速增殖细胞,如肿瘤细胞。

相似文献

1
Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation.一种针对人源和鼠源胞质胸苷激酶C末端部分的肽抗体的特性分析,该激酶是细胞增殖的标志物。
Eur J Cell Biol. 1996 Jun;70(2):117-24.
2
Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.胞质胸苷激酶是乳腺癌的一种特异性组织病理学肿瘤标志物。
Int J Oncol. 2004 Oct;25(4):945-53.
3
Effect of C-terminal of human cytosolic thymidine kinase (TK1) on in vitro stability and enzymatic properties.人胞质胸苷激酶(TK1)C末端对体外稳定性和酶学性质的影响
Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1185-8. doi: 10.1080/15257770600894436.
4
Investigation on cell proliferation with a new antibody against thymidine kinase 1.用一种针对胸苷激酶1的新型抗体对细胞增殖进行研究。
Anal Cell Pathol. 2001;23(1):11-9. doi: 10.1155/2001/658312.
5
Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.通过免疫组织化学和cDNA分析检测非小细胞肺癌患者细胞增殖基因的表达
Oncol Rep. 2005 May;13(5):837-46.
6
Continuous increase in phosphorylation of cytosolic thymidine kinase during proliferation of rat hepatoma JB1 cells.大鼠肝癌JB1细胞增殖过程中胞质胸苷激酶磷酸化持续增加。
Oncol Rep. 2003 May-Jun;10(3):665-9.
7
Localization and characterization of the 86- and 84-kDa heat shock proteins in Hepa 1c1c7 cells.Hepa 1c1c7细胞中86 kDa和84 kDa热休克蛋白的定位与特性分析
Exp Cell Res. 1993 Dec;209(2):350-6. doi: 10.1006/excr.1993.1320.
8
Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1.一种针对人胸苷激酶1 C末端肽产生的新型鸡IgY抗体的制备与特性分析
J Immunol Methods. 2003 Jun 1;277(1-2):157-69. doi: 10.1016/s0022-1759(03)00062-0.
9
Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I). Immuno-dominant and immuno-recessive area.PSP94(94个氨基酸的前列腺分泌蛋白)的表位结构分析:(I). 免疫显性和免疫隐性区域。
J Cell Biochem. 1997 May;65(2):172-85.
10
New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E.
Cancer Res. 1994 Apr 1;54(7):1831-6.

引用本文的文献

1
Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.分析和临床特征优化双单克隆夹心 ELISA 法检测人血样本胸苷激酶 1 (TK1)蛋白。
PLoS One. 2022 Oct 6;17(10):e0275444. doi: 10.1371/journal.pone.0275444. eCollection 2022.
2
Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker.猫胸苷激酶 1:分子特征及其血清形式作为诊断生物标志物的评估。
BMC Vet Res. 2021 Sep 27;17(1):316. doi: 10.1186/s12917-021-03030-5.
3
STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data.
基于真实世界数据,STK1p作为非小细胞肺癌总生存期的预后生物标志物。
Future Sci OA. 2020 Nov 23;7(3):FSO661. doi: 10.2144/fsoa-2020-0130.
4
Thymidine kinase 1 through the ages: a comprehensive review.胸腺嘧啶激酶1的历史沿革:一篇综述
Cell Biosci. 2020 Nov 27;10(1):138. doi: 10.1186/s13578-020-00493-1.
5
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.对乳腺癌患者血清进行的TK 210酶联免疫吸附测定临床评估表明,该测定在疾病各阶段均具有高敏感性和特异性。
Tumour Biol. 2016 Sep;37(9):11937-11945. doi: 10.1007/s13277-016-5024-z. Epub 2016 Apr 14.
6
Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.核 TK1 表达是宫颈癌前病变和恶性病变患者生存的独立预后因素。
BMC Cancer. 2013 May 21;13:249. doi: 10.1186/1471-2407-13-249.
7
Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings.在常规临床环境中,血清胸苷激酶 1 与临床分期和临床反应相关,并可监测 1247 例癌症患者的治疗结果。
Int J Clin Oncol. 2010 Aug;15(4):359-68. doi: 10.1007/s10147-010-0067-4. Epub 2010 Apr 1.
8
Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients.血清胸苷激酶 1 浓度作为化疗治疗非霍奇金淋巴瘤患者的预后因素。
J Cancer Res Clin Oncol. 2010 Aug;136(8):1193-9. doi: 10.1007/s00432-010-0769-z. Epub 2010 Feb 7.
9
Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.中国慢性淋巴细胞白血病患者血清胸苷激酶1浓度及其与其他预后因素的相关性。
Int J Hematol. 2009 Sep;90(2):205-211. doi: 10.1007/s12185-009-0380-8. Epub 2009 Jul 24.
10
Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.人脱氧核糖核苷激酶和核糖核苷激酶对抗病毒和抗癌核苷类似物的底物特异性及磷酸化作用
Pharmacol Ther. 2003 Nov;100(2):119-39. doi: 10.1016/j.pharmthera.2003.07.001.